Michael Loew

506 total citations
17 papers, 396 citations indexed

About

Michael Loew is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Loew has authored 17 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Michael Loew's work include Atrial Fibrillation Management and Outcomes (2 papers), Smoking Behavior and Cessation (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Michael Loew is often cited by papers focused on Atrial Fibrillation Management and Outcomes (2 papers), Smoking Behavior and Cessation (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Michael Loew collaborates with scholars based in Germany, Austria and United States. Michael Loew's co-authors include Hermann Brenner, Dietrich Rothenbacher, Barry D. Kuban, Morton H. Friedman, Gerhard Rappitsch, Karl Perktold, Michael Höfer, Dorothee Twardella, H Ziegler and Christa Stegmaier and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Clinical Epidemiology and Journal of Biomechanics.

In The Last Decade

Michael Loew

16 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Loew Germany 9 144 134 94 59 53 17 396
Carol Porth United States 6 114 0.8× 140 1.0× 69 0.7× 68 1.2× 38 0.7× 10 483
C J Bulpitt United Kingdom 11 292 2.0× 100 0.7× 72 0.8× 82 1.4× 22 0.4× 18 508
Christian Conseiller France 8 80 0.6× 222 1.7× 104 1.1× 62 1.1× 38 0.7× 10 467
Nafisseh S. Warner United States 12 66 0.5× 181 1.4× 55 0.6× 35 0.6× 91 1.7× 37 442
Rainhild Schäfers Germany 13 222 1.5× 108 0.8× 92 1.0× 41 0.7× 26 0.5× 39 560
Mohammed Minhaj United States 12 149 1.0× 124 0.9× 61 0.6× 93 1.6× 92 1.7× 38 472
Michael Gayle United States 14 79 0.5× 129 1.0× 64 0.7× 107 1.8× 78 1.5× 28 532
Guillaume Besch France 14 132 0.9× 152 1.1× 52 0.6× 182 3.1× 24 0.5× 39 616
Lenore R. Zohman United States 13 404 2.8× 106 0.8× 77 0.8× 94 1.6× 37 0.7× 40 674
Khaled Albouaini United Kingdom 11 426 3.0× 121 0.9× 62 0.7× 165 2.8× 29 0.5× 24 668

Countries citing papers authored by Michael Loew

Since Specialization
Citations

This map shows the geographic impact of Michael Loew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Loew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Loew more than expected).

Fields of papers citing papers by Michael Loew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Loew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Loew. The network helps show where Michael Loew may publish in the future.

Co-authorship network of co-authors of Michael Loew

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Loew. A scholar is included among the top collaborators of Michael Loew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Loew. Michael Loew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Loew, Michael, Michael M. Hoffmann, Harry Hahmann, et al.. (2006). Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 13(3). 449–456. 2 indexed citations
2.
Loew, Michael, Michael M. Hoffmann, Harry Hahmann, et al.. (2006). Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 13(3). 449–456. 2 indexed citations
3.
Twardella, Dorothee, Michael Loew, Dietrich Rothenbacher, et al.. (2005). The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. Journal of Clinical Epidemiology. 59(1). 82–89. 107 indexed citations
4.
Loew, Michael, Michael M. Hoffmann, Harry Hahmann, et al.. (2005). Smoking, apolipoprotein???E genotype, and early onset of coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 12(3). 268–270. 4 indexed citations
5.
Twardella, Dorothee, Michael Loew, Dietrich Rothenbacher, et al.. (2005). The impact of body weight on smoking cessation in German adults. Preventive Medicine. 42(2). 109–113. 24 indexed citations
6.
Loew, Michael, Michael M. Hoffmann, Harry Hahmann, et al.. (2005). Smoking, apolipoprotein E genotype, and early onset of coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 12(3). 268–270. 5 indexed citations
7.
Loew, Michael, Michael M. Hoffmann, Wolfgang Köenig, Hermann Brenner, & Dietrich Rothenbacher. (2005). Genotype and Plasma Concentration of Cystatin C in Patients With Coronary Heart Disease and Risk for Secondary Cardiovascular Events. Arteriosclerosis Thrombosis and Vascular Biology. 25(7). 1470–1474. 38 indexed citations
8.
Loew, Michael, Heiner Boeing, Til Stürmer‎, & Hermann Brenner. (2003). Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gamma-glutamyltransferase. Alcohol. 29(3). 131–135. 14 indexed citations
9.
Erfurth, Andreas, et al.. (2001). Depressive Störungen in der neurologischen Rehabilitation: Therapie mit Paroxetin. Psychiatrische Praxis. 28(1). 43–44. 8 indexed citations
10.
Schöttke, Henning, et al.. (2001). Perioden- und Lebenszeitprävalenzen von affektiven und Angststörungen bei Patienten mit einem Schlaganfall. Zeitschrift für Neuropsychologie. 12(4). 256–263. 1 indexed citations
11.
Barletta, Jeffrey F., Brian L. Erstad, Michael Loew, & Samuel M. Keim. (2000). A Prospective Study of Pain Control in the Emergency Department. American Journal of Therapeutics. 7(4). 251–255. 11 indexed citations
12.
Erfurth, Andreas, et al.. (1998). EKG-Veränderungen nach Paroxetin Drei Fallberichte. Der Nervenarzt. 69(7). 629–631. 11 indexed citations
13.
Erfurth, Andreas, et al.. (1998). EKG-Veränderungen nach Paroxetin. Der Nervenarzt. 69(7). 629–631. 18 indexed citations
14.
Perktold, Karl, Michael Höfer, Gerhard Rappitsch, et al.. (1997). Validated computation of physiologic flow in a realistic coronary artery branch. Journal of Biomechanics. 31(3). 217–228. 146 indexed citations
15.
Nelson, Mark A., Bernard W. Futscher, Michael Loew, & G. Tim Bowden. (1992). Analysis of the Harvey ras gene in cisplatin-initiated mouse skin tumors by polymerase chain reaction and direct DNA sequencing. Cancer Letters. 65(1). 27–33. 2 indexed citations
16.
Loew, Michael, et al.. (1989). [Multiple sclerosis: atrophy of the corpus callosum and psychosyndrome].. PubMed. 60(7). 414–9. 2 indexed citations
17.
Loew, Michael. (1956). [Prognosis of lymphogranulomatosis].. PubMed. 202(6). 700–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026